greeksoup/ stock research
Stock research / United States / KYMR / 13F holders

Kymera Therapeutics, Inc. 13F holders

276 funds reported a position in Kymera Therapeutics, Inc. in their 13F for the quarter ended 30 June 2026, together 97.0 million shares worth $11.09 billion. Against the quarter before, 42 opened a position, 96 added, 83 trimmed and 26 sold out; together they sold a net 38,863 shares. The largest holders: FMR LLC, Baker Bros. Advisors LP and Avoro Capital Advisors LLC.

Funds holding276+20 on Q1 2026
Shares they held97.0Mworth $11.09 billion
Net sold on the quarter38,863 sharesabout $4.4 million at the funds' values
Funds buying to selling138 to 109opened or added, to cut or sold
Opened 42Added 96Held 53Trimmed 83Sold out 26
Opened: 42 fundsAdded: 96 fundsHeld: 53 fundsTrimmed: 83 fundsSold out: 26 funds

What each fund did in KYMR against its 13F for the quarter before; a change under 0.1% of a holding counts as held

Q3 2024: 176 funds, 69.2 million shares176Q3 2024Q4 2024: 180 funds, 71.7 million shares180Q4 2024Q1 2025: 173 funds, 72.9 million shares173Q1 2025Q2 2025: 210 funds, 79.0 million shares210Q2 2025Q3 2025: 210 funds, 81.1 million shares210Q3 2025Q4 2025: 255 funds, 90.0 million shares255Q4 2025Q1 2026: 256 funds, 96.3 million shares256Q1 2026Q2 2026: 276 funds, 97.0 million shares276Q2 2026

Funds reporting a position in KYMR in their 13F, each quarter; hover a bar for the shares they held

Filed so far for the quarter to 30 September 2026

2,671 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 31 reported a position in Kymera Therapeutics, Inc.: 6 opened one, 10 added, 5 trimmed and 2 sold out, a net 10,852 shares bought.

FundChange in sharesShares nowStatusFiling
Harbor Capital Advisors, Inc.-5,98530,383trimmed13F
Inspire Investing, LLC+4,3164,316new13F
Assetmark, Inc.+3,8753,883added13F
NorthCrest Asset Manangement, LLC+2,3572,357new13F
Tema Etfs LLC+2,0382,038new13F
PSP Research LLC-2,0002,000trimmed13F
Sterling Capital Management LLC+1,5181,919added13F
Wealth Enhancement Advisory Services, LLC+3,1033,103new13F
Nisa Investment Advisors, LLC+6522,073added13F
IFP Advisors, Inc+518737added13F
Gamma Investing LLC+360814added13F
Mather Group, LLC.+200200new13F
Abel Hall, LLC+1894,870added13F
Farther Finance Advisors, LLC-13543trimmed13F
GF Fund Management Co. Ltd-1331,596trimmed13F
Keudell/Morrison Wealth Management+505,265added13F
SBI Securities Co., Ltd.-45241trimmed13F
Physician Wealth Advisors, Inc.+1623added13F
Cape Investment Advisory, Inc.+1111new13F
Versant Capital Management, Inc+11112added13F
Signaturefd, LLC+1168added13F
AdvisorNet Financial, Inc-600sold out13F
Stone House Investment Management, LLC-50sold out13F

The largest moves in the name among the funds that have filed, against each fund's previous 13F.

The well-known funds

Of the 44 funds followed here, 7 reported a position in Kymera Therapeutics, Inc. in a 13F for the quarter ended 30 June 2026. The largest: FMR LLC, 12.3 million shares worth $1.42 billion, 0.1% of its reported book. In the quarter, 3 funds added or opened a position and 3 trimmed or sold out; together they bought a net 577,481 shares, about $66.2 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.

FundSharesValueOf its bookChange on the quarterStatusQuarter endedFiling
FMR LLC12,349,256$1.42 billion0.1%+649,306added30 June 202613F
Geode Capital Management1,816,331$208.3 million0.0%+170,981added30 June 202613F
Capital Research Global Investors1,388,881$159.3 million0.0%-284,394trimmed30 June 202613F
Norges Bank757,246$86.8 million0.0%held30 June 202613F
Two Sigma Investments371,374$42.6 million0.0%+114,873added30 June 202613F
Alyeska276,455$31.7 million0.1%-66,243trimmed30 June 202613F
Citadel Advisors111,555$12.8 million0.0%-7,042trimmed30 June 202613F
Value is what the fund reported.
Read moreChange is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.

The largest holders

FundSharesShare of allValueOf its bookChange in sharesFiling
FMR LLC12,349,25612.73%$1.42 billion0.06%+649,30613F
Baker Bros. Advisors LP8,657,2428.92%$992.7 million4.99%no change13F
Avoro Capital Advisors LLC7,474,7477.71%$857.1 million7.70%no change13F
Price T Rowe Associates Inc.7,112,9807.33%$815.6 million0.08%+1,052,13313F
T. Rowe Price Investment Management, Inc.6,257,2616.45%$717.5 million0.47%+792,26413F
BlackRock, Inc.5,538,2105.71%$635.1 million0.01%+477,33413F
BVF Inc.3,872,0523.99%$444.0 million11.35%-1,630,65813F
Wellington Management Group LLP3,675,0283.79%$421.4 million0.07%-214,65913F
Vanguard Portfolio Management LLC2,992,1933.08%$343.1 million0.01%+118,13713F
Siren, L.L.C.2,935,8303.03%$336.7 million6.83%-251,00013F
Vanguard Capital Management LLC2,932,3783.02%$336.3 million0.01%+52,05413F
Atlas Venture Life Science Advisors, LLC2,847,5412.94%$326.5 million37.05%-1,730,46713F
State Street Corp.2,737,2262.82%$313.9 million0.01%+347,45913F
Geode Capital Management, LLC1,816,3311.87%$208.3 million0.01%+170,98113F
Capital Research Global Investors1,388,8811.43%$159.3 million0.02%-284,39413F
Goldman Sachs Group Inc.1,187,3331.22%$136.2 million0.01%+298,92413F
UBS Group AG1,007,7771.04%$115.6 million0.02%-16,07513F
Driehaus Capital Management LLC919,2330.95%$105.4 million0.61%-124,35013F
Merck & Co., Inc.772,1650.80%$88.5 million16.82%no change13F
Norges Bank757,2460.78%$86.8 million0.01%13F
Federated Hermes, Inc.749,3980.77%$85.9 million0.12%+212,71813F
Dimensional Fund Advisors LP745,1520.77%$85.4 million0.01%+152,27313F
Frontier Capital Management Co. LLC740,8660.76%$85.0 million0.79%-18,98213F
UBS AM, a distinct business unit of UBS Asset Management Americas LLC736,8660.76%$84.5 million0.01%-139,00613F
AllianceBernstein L.P.981,5211.01%$81.8 million0.03%+93,48613F
Holocene Advisors, LP636,5790.66%$73.0 million0.17%-200,18013F
Northern Trust Corp.581,9070.60%$66.7 million0.01%+87,46813F
Charles Schwab Investment Management Inc.529,7290.55%$60.7 million0.01%+34,46713F
Franklin Resources Inc.515,0500.53%$59.1 million0.01%+153,27813F
Eventide Asset Management, LLC504,2100.52%$57.8 million0.77%-122,71513F
Jennison Associates LLC502,9780.52%$57.7 million0.04%-6,02113F
Woodline Partners LP500,8680.52%$57.4 million0.18%+297,28313F
Rock Springs Capital Management LP453,1560.47%$52.0 million2.54%-43,71513F
Vanguard Fiduciary Trust Co.449,7310.46%$51.6 million0.01%+22,34913F
Boxer Capital Management, LLC429,1000.44%$49.2 million3.71%+100,00013F
Pictet Asset Management Holding SA395,5400.41%$45.0 million0.04%-73,18813F
Bank of America Corp.378,2860.39%$43.4 million0.00%+88,87013F
Braidwell LP378,1630.39%$43.4 million1.67%+40,60413F
BNP Paribas Financial Markets375,8680.39%$43.1 million0.02%+89,99713F
Two Sigma Investments, LP371,3740.38%$42.6 million0.03%+114,87313F
Clearbridge Investments, LLC347,2210.36%$39.8 million0.03%new13F
Octagon Capital Advisors LP310,0000.32%$35.5 million3.26%-115,00013F
Nextech Invest Ltd.278,8960.29%$32.0 million1.52%no change13F
Alyeska Investment Group, L.P.276,4550.28%$31.7 million0.08%-66,24313F
TD Asset Management Inc272,9000.28%$31.3 million0.03%-14,20013F
Voya Investment Management LLC269,9140.28%$31.0 million0.03%+71,10613F
Commodore Capital LP250,0000.26%$28.7 million1.71%-500,00013F
RTW Investments, LP240,0000.25%$27.5 million0.23%no change13F
Massachusetts Financial Services Co.233,7130.24%$26.8 million0.01%+24,70813F
Gilder Gagnon Howe & Co. LLC229,0530.24%$26.3 million0.27%-6,38013F
The 50 largest of the 276 funds that reported a position in KYMR in their 13F for the quarter ended 30 June 2026, by the value each reported.
Read moreShare of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?

Options the funds reported on KYMR

FundOptionShares under the optionsValue of those sharesQuarter endedFiling
Citadel AdvisorsPuts33,500$3.8 million30 June 202613F
Citadel AdvisorsCalls29,900$3.4 million30 June 202613F
A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost.
Read moreThey are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.

Schedule 13D and 13G filed on the name, last twelve months

FiledScheduleWhoHoldingOf the classEvent dateRule or purposeFiling
27 October 202613G/ABlackRock, Inc. and 1 other5.5 million6.6%30 September 2026passive, institutional (13d-1(b))EDGAR
8 September 202613G/AT. Rowe Price Associates, Inc. and 1 other8.9 million10.7%31 August 2026passive, institutional (13d-1(b))EDGAR
14 August 202613G/AT. Rowe Price Associates, Inc. and 1 other7.1 million8.6%30 June 2026passive, institutional (13d-1(b))EDGAR
13 August 202613G/AAtlas Venture Fund X, L.P. and 11 others2.4 million2.9%30 June 2026passive, other (13d-1(d))EDGAR
26 June 202613D/ABiotechnology Value Fund L P and 10 others5.2 million6.3%26 June 2026EDGAR
15 May 202613GT. Rowe Price Investment Management, Inc. and 1 other5.5 million6.7%31 March 2026passive, institutional (13d-1(b))EDGAR
15 May 202613G/AWellington Management Group LLP and 5 others3.9 million4.8%31 March 2026passive, institutional (13d-1(b))EDGAR
6 May 202613G/AFMR LLC and 3 others11.7 million14.3%31 March 2026passive, institutional (13d-1(b))EDGAR
27 March 202613G/AThe Vanguard Group and 1 other00.0%13 March 2026passive, institutional (13d-1(b))EDGAR
10 February 202613G/AWellington Management Group LLP and 7 others4.4 million5.5%31 December 2025passive, institutional (13d-1(b))EDGAR
8 January 202613G/AFMR LLC and 3 others8.9 million11.2%31 December 2025passive, institutional (13d-1(b))EDGAR
15 December 202513D/ABiotechnology Value Fund L P and 10 others6.9 million8.5%11 December 2025EDGAR
11 December 202513D/ABaker Bros. Advisors LP and 3 others8.7 million10.9%9 December 2025Item 4 of Amendment No. 3 is supplemented and amended, as the case may be, as follows: The disclosure in Item 3 and in Item 6 below is incorporated herein by reference. On December 9, 2025, the Issuer entered into an underwriting agreement EDGAR
14 November 202513G/AT. Rowe Price Associates, Inc. and 1 other5.1 million7.1%30 September 2025passive, institutional (13d-1(b))EDGAR
5 November 202513G/AFMR LLC and 3 others5.9 million8.2%30 September 2025passive, institutional (13d-1(b))EDGAR
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read moreAmendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13G

Fails to deliver

Settlement dateShares failedPriceFile
22 September 20261,242$117.67SEC
11 September 202610,096$117.00SEC
4 September 2026369$117.28SEC
25 August 202612$121.05SEC
21 August 20261,329$121.50SEC
19 August 20262$121.38SEC
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read moreLargest in the window: 10,096 on 11 September 2026. A fail is an operational fact about settlement, not a position.